Format

Send to

Choose Destination
Sex Transm Dis. 2007 Dec;34(12):954-9.

Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age.

Author information

1
National Institutes of Health, Rockville, Maryland, USA. bnx4@cdc.gov

Abstract

OBJECTIVES:

This study examined whether hormonal contraceptive use is associated with diagnosis of bacterial vaginosis (BV) over 1 year.

STUDY DESIGN:

A total of 3,077 women of reproductive age were recruited from gynecologic and family planning clinics for a 1-year prospective longitudinal study. Data collected over 5 visits included demographics, health and hygiene behaviors, and gynecological exams. Gram stains were used to quantify vaginal flora.

RESULTS:

There was a decreased risk of overall BV prevalence among oral contraceptive users (odds ratio, OR 0.76; confidence interval, CI 0.63-0.90) and among those using hormonal injection/implant (OR 0.64; CI 0.53-0.76). An increased risk for BV prevalence (OR 1.38; CI 1.11-1.71) and incidence (OR 1.43; 1.02-2.07) was observed among those subjects who had tubal ligation. Greater remission of BV was found among those using hormonal injection or implant (OR 1.67; CI 1.23-2.27) whereas less remission occurred among those subjects who had tubal ligation (OR 0.56; CI 0.39-0.80).

CONCLUSIONS:

Hormonal contraceptive use is associated with a decreased risk of BV.

PMID:
18077845
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center